Direxion Shares ETF Trust Direxion Daily AI and Big Data Bear 2X Shares (ARCA: AIBD)

에 대한 최신 뉴스 Direxion Shares ETF Trust Direxion Daily AI and Big Data Bear 2X Shares (ARCA:AIBD)

Direxion Shares ETF Trust Direxion Daily AI and Big Data Bear 2X Shares

The Index is designed by Solactive AG (the Index Provider) to represent the securities of companies from the United States that have business operations in the field of artificial intelligence (AI) applications and big data

Dreyfus Govt Cash Man Ins

Dreyfus Trsy Prime Cash Mgmt - In 0 -

Gs Financial Square Treasury Instruments Fund

Direxion Daily AI and Big Data Bear 2X Shares

Etf,Exchange-traded,Fund,Stock,Market,Trading,Investment,Financial,Concept.

Broad U.S. Equity ETFs

ETFs

AIBD

NVDA

RIVN

SHNY

TSLA

Barclays Bank iPath S&P 500 VIX Short-Term Futures ETN

투자자 심리는 지난주 도널드 트럼프 대통령이 자동차 수입에 25%의 관세를 부과한다고 발표했을 때 충격을 받았다. 이는 인플레이션 우려를 증가시키고 시장을 흔들었다. 인플레이션 수치는 예상보다 뜨거웠고, 소비자 신뢰가 흔들렸다며 국가 부채 전망이 악화되었다.

관세, 인플레이션 및 시장 하락: 지난주의 혼돈 속에서 성과를 보인 5개의 ETF

Investors with a lot of money to spend have taken a bullish stance on Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MU, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 89 uncommon options trades for Micron Technology.
This isn't normal.
The overall sentiment of these big-money traders is split between 51% bullish and 35%, bearish.
Out of all of the special options we uncovered, 20 are puts, for a total amount of $1,164,979, and 69 are calls, for a total amount of $4,360,018.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $195.0 for Micron Technology over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Micron Technology's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Micron Technology's substantial trades, within a strike price spectrum from $55.0 to $195.0 over the preceding 30 days.
<h3>Micron Technology 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750183269_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$25.6</td>
<td>$25.55</td>
<td>$25.6</td>
<td>$100.00</td>
<td>$179.2K</td>
<td>7.4K</td>
<td>90</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$46.35</td>
<td>$46.1</td>
<td>$46.25</td>
<td>$75.00</td>
<td>$161.8K</td>
<td>8.5K</td>
<td>88</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$51.0</td>
<td>$50.7</td>
<td>$51.0</td>
<td>$70.00</td>
<td>$153.0K</td>
<td>3.6K</td>
<td>30</td>
</tr>
<tr>
<td>MU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$2.56</td>
<td>$2.52</td>
<td>$2.52</td>
<td>$100.00</td>
<td>$123.9K</td>
<td>4.9K</td>
<td>4.2K</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$8.75</td>
<td>$8.7</td>
<td>$8.75</td>
<td>$125.00</td>
<td>$123.3K</td>
<td>3.6K</td>
<td>685</td>
</tr>
</tbody>
</table>

<h3>About Micron Technology</h3>
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.
Following our analysis of the options activities associated with Micron Technology, we pivot to a closer look at the company's own performance.
<h3>Current Position of Micron Technology</h3>
<ul>
<li>Trading volume stands at 14,039,863, with MU's price up by 1.05%, positioned at $121.1.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 8 days.</li>
</ul>
<h3>What Analysts Are Saying About Micron Technology</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $126.67.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Micron Technology with a target price of $120. 
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Micron Technology, which currently sits at a price target of $130. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Micron Technology with a target price of $130. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Micron Technology with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

A Closer Look at Micron Technology's Options Market Dynamics

Commerce Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBSH#NASDAQ">CBSH</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $63.0, with a high estimate of $70.00 and a low estimate of $58.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 5.41%. 
<img src="https://www.benzinga.com/files/images/story/2025/1750183267_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Commerce Bancshares by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$61.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Nathan Race</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$70.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$58.00</td>
<td>$66.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Commerce Bancshares. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Commerce Bancshares compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Commerce Bancshares's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Commerce Bancshares's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CBSH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Commerce Bancshares analyst ratings.</a>
<h2>All You Need to Know About Commerce Bancshares</h2>
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.
<h3>Commerce Bancshares's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, Commerce Bancshares showcased positive performance, achieving a revenue growth rate of 5.75% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Commerce Bancshares's net margin excels beyond industry benchmarks, reaching 31.0%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Commerce Bancshares's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.84%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Commerce Bancshares's ROA stands out, surpassing industry averages. With an impressive ROA of 0.4%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Commerce Bancshares's debt-to-equity ratio is below the industry average at 0.01, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

CBSH

Deep Dive Into Commerce Bancshares Stock: Analyst Perspectives (5 Ratings)

Whales with a lot of money to spend have taken a noticeably bearish stance on Arista Networks.
Looking at options history for Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $63,960 and 7, calls, for a total amount of $401,398.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $45.0 to $100.0 for Arista Networks over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Arista Networks's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Arista Networks's substantial trades, within a strike price spectrum from $45.0 to $100.0 over the preceding 30 days.
<h3>Arista Networks 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750183264_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$10.5</td>
<td>$10.4</td>
<td>$10.5</td>
<td>$90.00</td>
<td>$105.0K</td>
<td>2.1K</td>
<td align="right">220</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$10.5</td>
<td>$10.3</td>
<td>$10.5</td>
<td>$90.00</td>
<td>$105.0K</td>
<td>2.1K</td>
<td align="right">20</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$27.6</td>
<td>$27.1</td>
<td>$27.26</td>
<td>$70.00</td>
<td>$54.5K</td>
<td>774</td>
<td align="right">20</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$16.2</td>
<td>$16.0</td>
<td>$16.08</td>
<td>$80.00</td>
<td>$48.2K</td>
<td>1.1K</td>
<td align="right">87</td>
</tr>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$17.0</td>
<td>$16.8</td>
<td>$16.8</td>
<td>$95.00</td>
<td>$36.9K</td>
<td>404</td>
<td align="right">22</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
In light of the recent options history for Arista Networks, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Arista Networks</h3>
<ul>
<li>Trading volume stands at 5,967,494, with ANET's price down by -4.0%, positioned at $91.28.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 42 days.</li>
</ul>
<h3>What The Experts Say On Arista Networks</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $112.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Redburn Atlantic has revised its rating downward to Buy, adjusting the price target to $112. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Arista Networks, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

ANET

Arista Networks Options Trading: A Deep Dive into Market Sentiment

B of A Securities analyst Tal Liani maintains Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) with a Buy and lowers the price target from $245 to $200.

News

Price Target

QCOM

B of A Securities Maintains Buy on Qualcomm, Lowers Price Target to $200

Investors with a lot of money to spend have taken a bullish stance on Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NFLX, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 93 uncommon options trades for Netflix.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 34%, bearish.
Out of all of the special options we uncovered, 36 are puts, for a total amount of $2,309,578, and 57 are calls, for a total amount of $3,231,469.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $450.0 to $1750.0 for Netflix over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Netflix's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Netflix's substantial trades, within a strike price spectrum from $450.0 to $1750.0 over the preceding 30 days.
<h3>Netflix 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750183259_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$57.0</td>
<td>$56.45</td>
<td>$57.0</td>
<td>$1225.00</td>
<td>$210.9K</td>
<td align="right">80</td>
<td align="right">45</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$367.0</td>
<td>$362.5</td>
<td>$367.0</td>
<td>$1160.00</td>
<td>$183.5K</td>
<td align="right">42</td>
<td align="right">5</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$180.5</td>
<td>$177.85</td>
<td>$180.5</td>
<td>$1220.00</td>
<td>$180.5K</td>
<td align="right">32</td>
<td align="right">21</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$157.9</td>
<td>$157.0</td>
<td>$157.0</td>
<td>$1200.00</td>
<td>$157.0K</td>
<td align="right">839</td>
<td align="right">10</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$132.65</td>
<td>$132.25</td>
<td>$132.25</td>
<td>$1260.00</td>
<td>$132.2K</td>
<td align="right">38</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Netflix</h3>
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
Following our analysis of the options activities associated with Netflix, we pivot to a closer look at the company's own performance.
<h3>Current Position of Netflix</h3>
<ul>
<li>With a trading volume of 941,567, the price of NFLX is down by -0.3%, reaching $1221.72.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 30 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Netflix</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $1336.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on Netflix, maintaining a target price of $1425. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Neutral rating for Netflix, targeting a price of $1250. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Netflix with a target price of $1450. 
&#x2A; An analyst from JP Morgan has revised its rating downward to Neutral, adjusting the price target to $1220. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Netflix, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

NFLX

This Is What Whales Are Betting On Netflix

Throughout the last three months, 10 analysts have evaluated Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $482.4, with a high estimate of $567.00 and a low estimate of $420.00. This current average reflects an increase of 0.62% from the previous average price target of $479.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1750183256_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Vertex Pharmaceuticals among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$420.00</td>
<td>$423.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$423.00</td>
<td>$420.00</td>
</tr>
<tr>
<td>Greg Harrison</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$442.00</td>
<td>$450.00</td>
</tr>
<tr>
<td>Matthew Harrison</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$464.00</td>
<td>$462.00</td>
</tr>
<tr>
<td>Jessica Fye</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$515.00</td>
<td>$512.00</td>
</tr>
<tr>
<td>Carter Gould</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$535.00</td>
<td>$535.00</td>
</tr>
<tr>
<td>David Risinger</td>
<td>Leerink Partners</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$503.00</td>
<td>$550.00</td>
</tr>
<tr>
<td>Carter Gould</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$535.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$420.00</td>
<td>$408.00</td>
</tr>
<tr>
<td>Ying Huang</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$567.00</td>
<td>$555.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Vertex Pharmaceuticals. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Vertex Pharmaceuticals compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Vertex Pharmaceuticals's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Vertex Pharmaceuticals's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VRTX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Vertex Pharmaceuticals analyst ratings.</a>
<h2>About Vertex Pharmaceuticals</h2>
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
<h3>Vertex Pharmaceuticals: Financial Performance Dissected</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Vertex Pharmaceuticals displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 2.96%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Vertex Pharmaceuticals's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 23.33%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Vertex Pharmaceuticals's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.93%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.85%, the company showcases effective utilization of assets.
Debt Management: Vertex Pharmaceuticals's debt-to-equity ratio is below the industry average at 0.1, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VRTX

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts

During the last three months, 15 analysts shared their evaluations of Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $1084.47, a high estimate of $1225.00, and a low estimate of $975.00. Experiencing a 0.96% decline, the current average is now lower than the previous average price target of $1095.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1750183248_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Costco Wholesale among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$1060.00</td>
<td>$1075.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1225.00</td>
<td>$1150.00</td>
</tr>
<tr>
<td>Laura Champine</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$1110.00</td>
<td>$1115.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1075.00</td>
<td>$1070.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$1042.00</td>
<td>$995.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>David Belinger</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Neutral</td>
<td>$975.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Laura Champine</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$1045.00</td>
<td>$1150.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$1100.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$1035.00</td>
<td>$1075.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Costco Wholesale. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Costco Wholesale compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Costco Wholesale's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Costco Wholesale's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/COST/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Costco Wholesale analyst ratings.</a>
<h2>Unveiling the Story Behind Costco Wholesale</h2>
Costco operates a membership-based, no-frills retail model predicated on offering a select product assortment in bulk quantities at bargain prices. The firm avoids maintaining costly product displays by keeping inventory on pallets and limits distribution expenses by storing its inventory at point of sale in the warehouse. Given its frugal cost structure, the firm is able to price its merchandise below that of competing retailers, driving high sales volume per warehouse and generating strong profits on thin margins. Costco operates over 600 warehouses in the United States and has over 60% share in the domestic warehouse club industry. Internationally, Costco operates about 280 warehouses, primarily in Canada, Mexico, Japan, and the UK.
<h3>Costco Wholesale's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Positive Revenue Trend: Examining Costco Wholesale's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.02% as of 31 May, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Costco Wholesale's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 3.01%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Costco Wholesale's ROE excels beyond industry benchmarks, reaching 7.22%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Costco Wholesale's ROA stands out, surpassing industry averages. With an impressive ROA of 2.56%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.3, Costco Wholesale adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COST

15 Analysts Assess Costco Wholesale: What You Need To Know

4 analysts have expressed a variety of opinions on EyePoint Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for EyePoint Pharmaceuticals, presenting an average target of $25.75, a high estimate of $28.00, and a low estimate of $22.00. Experiencing a 9.11% decline, the current average is now lower than the previous average price target of $28.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1750183239_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive EyePoint Pharmaceuticals. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lisa Walter</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$28.00</td>
<td>-</td>
</tr>
<tr>
<td>Yi Chen</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Graig Suvannavejh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Daniil Gataulin</td>
<td>Chardan Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$27.00</td>
<td>$33.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to EyePoint Pharmaceuticals. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of EyePoint Pharmaceuticals compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for EyePoint Pharmaceuticals's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of EyePoint Pharmaceuticals's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EYPT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EyePoint Pharmaceuticals analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About EyePoint Pharmaceuticals</h2>
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
<h3>Understanding the Numbers: EyePoint Pharmaceuticals's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: EyePoint Pharmaceuticals displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 109.29%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: EyePoint Pharmaceuticals's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -184.82% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): EyePoint Pharmaceuticals's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -14.24%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): EyePoint Pharmaceuticals's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -11.57%, the company may face hurdles in achieving optimal financial performance.
Debt Management: EyePoint Pharmaceuticals's debt-to-equity ratio is below the industry average at 0.08, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EYPT

Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals

A former Bank of England economist is raising red flags over the growing role of stablecoins in the U.S. financial system, with major implications for banks, as well as the U.S. Dollar.
What Happened: In a recent episode of The Big View by Reuters, Dan Davies, an ex-BoE regulatory economist and veteran bank analyst, compared stablecoin issuers like Circle Internet Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) and Tether to banks that lack the oversight and safeguards of traditional institutions.
&#8220;These things are basically intrinsically unstable financial structures,&#8221; Davies said, noting that their promise of 1:1 redemption in U.S. dollars makes them particularly vulnerable to sudden runs, referring to bank runs, when a large number of individuals try to withdraw their funds from an institution at the same time.
He says, &#8220;If you think there's even a small chance that it [a stablecoin] might be worth 95 cents on the dollar, then you want to get out immediately.&#8221;
See Also: <a href="https://www.benzinga.com/news/events/25/06/45967070/howard-lutnick-says-nearly-70000-register-for-5-million-trump-card-visa-as-us-eyes-1-trillion-windfall-from-premium-immigration-plan">Howard Lutnick Says Nearly 70,000 Register For $5 Million &#8216;Trump Card&#8217; Visa As US Eyes $1 Trillion Windfall From Premium Immigration Plan</a>
Davies notes that stablecoin issuers hold significant reserves in commercial bank deposits and Treasury bills, so in case redemptions spike, the banks that hold these reserves could witness withdrawal demands in the billions.
&#8220;They're very bad customers for the banking system,&#8221; he says, pointing to the systemic stress this dynamic could introduce.
Circle, for instance, works <a href="https://www.circle.com/usdc">with</a> the Bank of New York Mellon Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) as its custodian, among a few others, while Tether works <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42166673/drug-cartels-use-tether-and-bitcoin-to-launder-millions-court-documents-reveal">with</a> Cantor Fitzergerald. 
According to Davies, the GENIUS Act, a bill introduced in Congress to regulate stablecoins, may end up doing more harm than good. 
While the legislation appears to offer guardrails, such as reserve disclosures and other transparency requirements, Davies believes that it could inadvertently normalize risk. 
On a global level, Davies said the move could accelerate &#8220;de-dollarization,&#8221; as countries seek to insulate their economies from the added volatility introduced by U.S.-backed stablecoins.
&#8220;Signing up to the U.S. dollar now means signing up to stablecoins,&#8221; he says, warning this could erode trust and encourage alternatives like central bank digital currencies in Europe and Asia.
Why It Matters: Davies&#8217; concerns have been echoed by several other prominent experts and institutions, such as the United States Financial Services Oversight Council (FSOC), which raised alarms over the <a href="https://www.benzinga.com/content/42377684/fsoc-warns-stablecoins-pose-stability-risks-due-to-lack-of-management-standards">potential risks posed</a> by stablecoins due to inadequate risk management standards late last year. 
There are, however, several other <a href="https://www.benzinga.com/24/12/42585826/stablecoins-redefining-global-finance-are-banks-falling-behind">voices in support</a> of this new asset class, such as Jan Van Eck, the CEO of VanEck, who said that &#8220;the global payments system is being rewired as we speak,&#8221; while referring to stablecoins and their utility in payments and cross-border transactions. 
Last month, it was reported that <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45579978/banking-giants-like-jpmorgan-bank-of-america-mull-joint-stablecoin-to-counter-crypto-competition-report">leading U.S. Banks</a>, including JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), Citigroup Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), and Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) were exploring the possibility of a joint stablecoin.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="147" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17054954/Screenshot-2025-06-17-at-3.19.38-PM-1024x147.png" alt="" class="wp-image-951944" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17054954/Screenshot-2025-06-17-at-3.19.38-PM-1024x147.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17054954/Screenshot-2025-06-17-at-3.19.38-PM-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17054954/Screenshot-2025-06-17-at-3.19.38-PM-768x110.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/17054954/Screenshot-2025-06-17-at-3.19.38-PM.png 1520w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
According to Benzinga&#8217;s Edge Stock Rankings, Circle has a favorable price trend in the short, medium, and long term, but how does it compare with peers and competitors? Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> to find out. 
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45967469/us-equity-funds-are-raking-in-billions-these-are-the-ones-beating-trumps-tariff-shock-in-2025">US Equity Funds Are Raking In Billions—These Are The Ones Beating Trump&#8217;s Tariff Shock in 2025</a></li>
</ul>
Photo courtesy: Grey82 / Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

CRCL

Stablecoins Pose 'Systemic Risk' To US Banks And Dollar, Former BoE Advisor Warns: 'They're Very Bad Customers For The Banking System'

Johnson &amp; Johnson's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) short percent of float has fallen 15.79% since its last report. The company recently reported that it has 19.22 million shares sold short, which is 0.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Johnson &amp; Johnson Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750183231_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Johnson &amp; Johnson has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Johnson &amp; Johnson's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Johnson &amp; Johnson's peer group average for short interest as a percentage of float is 4.04%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into Johnson & Johnson's Recent Short Interest

Ratings for Digital Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $187.11, along with a high estimate of $220.00 and a low estimate of $139.00. A decline of 1.58% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1750183229_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Digital Realty Trust by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Omotayo Okusanya</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$191.00</td>
<td>$177.00</td>
</tr>
<tr>
<td>Timothy Horan</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$200.00</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Hau</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$184.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$220.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Jonathan Petersen</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$193.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Maher Yaghi</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$206.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Michael Rollins</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$174.00</td>
<td>$188.00</td>
</tr>
<tr>
<td>Omotayo Okusanya</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$177.00</td>
<td>$211.00</td>
</tr>
<tr>
<td>Brendan Lynch</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$139.00</td>
<td>$142.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Digital Realty Trust. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Digital Realty Trust compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Digital Realty Trust's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Digital Realty Trust's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DLR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Digital Realty Trust analyst ratings.</a>
<h2>Delving into Digital Realty Trust's Background</h2>
Digital Realty owns and operates over 300 data centers worldwide. It has nearly 40 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to "cold shells," where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. The company operates as a real estate investment trust.
<h3>Financial Milestones: Digital Realty Trust's Journey</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Positive Revenue Trend: Examining Digital Realty Trust's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.75% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Digital Realty Trust's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 7.09%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Digital Realty Trust's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.48%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Digital Realty Trust's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.22%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Digital Realty Trust's debt-to-equity ratio is below the industry average at 0.89, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Digital Realty Trust: 9 Analysts Share Their Views

Texas Roadhouse's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NYSE">TXRH</a>) short percent of float has fallen 15.01% since its last report. The company recently reported that it has 2.77 million shares sold short, which is 4.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Texas Roadhouse Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750183226_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Texas Roadhouse has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Texas Roadhouse's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Texas Roadhouse's peer group average for short interest as a percentage of float is 10.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TXRH

What's Driving the Market Sentiment Around Texas Roadhouse?

In the current market session, TTM Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) stock price is at $37.00, after a 0.24% decrease. However, over the past month, the company's stock increased by 23.79%, and in the past year, by 91.19%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1750183224_0.png" alt="Past Year Chart" />

<h3>A Look at TTM Technologies P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 86.91 in the Electronic Equipment, Instruments &amp; Components industry, TTM Technologies Inc. has a lower P/E ratio of 49.45. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1750183224_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

TTMI

P/E Ratio Insights for TTM Technologies

Boyd Gaming's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) short percent of float has fallen 22.26% since its last report. The company recently reported that it has 2.76 million shares sold short, which is 4.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Boyd Gaming Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750183221_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Boyd Gaming has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Boyd Gaming's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Boyd Gaming's peer group average for short interest as a percentage of float is 7.94%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About Boyd Gaming?

In the latest quarter, 11 analysts provided ratings for Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">10</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $46.09, a high estimate of $50.00, and a low estimate of $35.00. Witnessing a positive shift, the current average has risen by 17.91% from the previous average price target of $39.09.
<img src="https://www.benzinga.com/files/images/story/2025/1750183218_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Advance Auto Parts among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$50.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Sam Hudson</td>
<td>Redburn Atlantic</td>
<td>Raises</td>
<td>Neutral</td>
<td>$45.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Scott Stember</td>
<td>Roth Capital</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Michael Baker</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$47.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Elizabeth Suzuki</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$39.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$48.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Tristan Thomas-Martin</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$50.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$48.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$45.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Advance Auto Parts. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Advance Auto Parts compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Advance Auto Parts's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Advance Auto Parts's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AAP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Advance Auto Parts analyst ratings.</a>
<h2>About Advance Auto Parts</h2>
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
<h3>A Deep Dive into Advance Auto Parts's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Advance Auto Parts's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -6.82%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Advance Auto Parts's net margin is impressive, surpassing industry averages. With a net margin of 0.93%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.1%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Advance Auto Parts's ROA excels beyond industry benchmarks, reaching 0.22%. This signifies efficient management of assets and strong financial health.
Debt Management: Advance Auto Parts's debt-to-equity ratio is below the industry average at 1.67, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Advance Auto Parts: 11 Analysts Share Their Views

B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) with a Neutral and lowers the price target from $320 to $260.

B of A Securities Maintains Neutral on Humana, Lowers Price Target to $260

<a href="https://www.bloomberg.com/news/articles/2025-06-17/harder-to-cut-with-core-inflation-elevated-bank-of-canada-says">https://www.bloomberg.com/news/articles/2025-06-17/harder-to-cut-with-core-inflation-elevated-bank-of-canada-says</a>

General

'Harder to Cut With Core Inflation Firm, Bank of Canada Says'- Bloomberg

Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares are trading lower on Tuesday after GLJ Research analyst Gordon L. Johnson II issued a <a href="https://www.benzinga.com/quote/RUN/analyst-ratings" target="_blank" rel="noreferrer noopener">downgrade for the stock</a> from Hold to Sell.
Johnson noted the underlying equity is worthless unless SunRun can inflate the value of its solar systems to collect tax credits.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45971345/sunrun-first-solar-plunge-solar-stocks-hit-hard-by-trump-tax-bill-latest" rel="noreferrer noopener">Sunrun, First Solar Plunge—Solar Stocks Hit Hard By Trump Tax Bill: Latest</a>
SunRun&#8217;s first-quarter 2025 financial disclosure, he said, currently has over one million systems on its balance sheet.
Johnson said that assuming each of SunRun&#8217;s systems is underwater by ~$600, SunRun burns $644.56 million annually in cash when considering the current systems it has in service, which assumes the company has stopped growing.
But, if SunRun stops growing, it cannot plug the -$644.56 million annual cash burn, creating a circular problem (the more SunRun grows, the more cash it burns), the analyst noted.
One of the benefits of perpetually understating O&amp;M costs is that it allows the overstatement of the value of the systems, enabling companies like SunRun, Sunnova and SunPower to claim tax credits beyond what would otherwise be available, he noted.
However, as detailed in the language from the U.S. Senate&#8217;s tax-and-spend bill, Johnson noted that residential solar finance companies would no longer be able to sell tax credits to third parties, which is potentially an existential threat to both SunRun and SolarEdge Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) and, to a lesser extent, Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>). Also, the analyst said the 45 times credits for solar production were left unchanged, marking an incremental positive for First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>).
In short, he noted that removing SunRun&#8217;s ability to sell tax credits to third parties and considering the company&#8217;s never making money creates a massive problem.
According to Johnson (like Sunnova and SunPower before it), covering the ~$600 per system hole inherent in SunRun&#8217;s business will quickly overwhelm the company, barring its ability to overstate the value of its systems and then garner tax credits on these overstated values. 
The key factor allowing SunRun to stay afloat has always been its ability to securitize loans or PPAs, bringing in hundreds of millions of new dollars each year, as per the analyst. 
He said that the company&#8217;s ability to securitize allowed it to cover the gap in its real O&amp;M expenses versus those it represented to the investing public. Yet, with the ability to securitize no longer there for SunRun (should the Senate&#8217;s version of the tax-and-spend pass), the company will quickly be unable to service its systems, Johnson said. 
The analyst noted that this task would fall on the sponsor equity, draining most of its cash flow, as it is below the tax equity investors in the partnership flip capital stack. This also means the sponsor equity investors in SunRuns&#8217; asset-backed security (&#8220;ABS&#8221;) bonds will quickly &#8220;head for the hills,&#8221; he added.
RUN Price Action: RUN stock is down 39.32% at $5.85 at publication on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45969168/amazon-extends-prime-day-in-july-as-tariff-hit-shoppers-hunt-bargain-deals" target="_blank" rel="noreferrer noopener">Amazon Extends Prime Day In July As Tariff-Hit Shoppers Hunt Bargain Deals</a></li>
</ul>
Photo: Shutterstock

Downgrades

ENPH

FSLR

SEDG

Sunrun Receives Downgrade As Analyst Warns Business Model Relies On Inflated System Values For Tax Credits

B of A Securities analyst Ruplu Bhattacharya maintains Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Buy and raises the price target from $85 to $100.

ROKU

B of A Securities Maintains Buy on Roku, Raises Price Target to $100

WIIM

BITF

CLSK

COIN

HIVE

MARA

MSTR

RIOT

Shares of crypto-linked stocks are trading lower as risk sentiment pull back amid concerns of Israel-Iran escalation.

The Risks And Rewards Of Betting Big On AI & Big Data

AAPL

AIBU

AMZN

GOOG

MSFT

투자자 심리는 지난주 도널드 트럼프 대통령이 자동차 수입에 25%의 관세를 부과한다고 발표했을 때 충격을 받았다. 이는 인플레이션 우려를 증가시키고 시장을 흔들었다. 인플레이션 수치는 예상보다 뜨거웠고, <a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44380264/consumer-spending-stumbles-time-to-buy-the-dip-in-retail-etfs">소비자 신뢰가 흔들렸다</a>며 국가 부채 전망이 악화되었다.
시장 변동성에도 불구하고, 성과를 낸 다섯 개의 <a href="https://www.benzinga.com/etfs">ETF</a>가 언급될 만하다:
마이크로섹터스 골드 3X 레버리지 ETN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHNY#NYSE">SHNY</a>) – 인플레이션 우려와 세계적 불확실성 증가로 투자자들이 금으로 몰려들면서 이 상장지수채권(ETN)은 상승세를 보였다.
주간 상승률: 7.22%
비용 비율: 0.95%
그래니트셰어스 2x 숏 NVDA 데일 ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVD#NASDAQ">NVD</a>) – 인공지능(AI) 칩 거대 기업 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)가 어려움을 겪는 동안, 이 레버리지 역방향 ETF는 하락세를 타고 랠리를 펼쳤다.
주간 상승률: 21%
비용 비율: 1.5%
디렉시온 데일리 AI 및 빅데이터 베어 2X 주식 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIBD#NYSE">AIBD</a>) – AI 주식들이 전반적인 위험 회피 심리로 인해 어려움을 겪는 동안, 이 베어 ETF는 강력한 수익을 올렸다.
주간 상승률: 14.4%
비용 비율: 1.04%
T-렉스 2X 인버스 이더 데일 타깃 ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ETQ#BATS">ETQ</a>) – 이 인버스 이더리움 ETF는 암호화폐 시장의 변동성이 계속되면서 이더의 하락으로 혜택을 보았다.
주간 상승률: 22.8%
비용 비율: 1.25%
아이패스 시리즈 B S&amp;P 500 VIX 단기 선물 ETN (BATS:<a class="ticker" href="https://www.benzinga.com/stock/VXX#BATS">VXX</a>) – 시장의 불확실성이 커짐에 따라 변동성이 상승했고, 이 ETN은 단기 VIX 선물로 수익을 올렸다.
주간 상승률: 13.14%
비용 비율: 0.89%
지난주 시장 성과
자동차 일괄 관세 소식은 주식 시장을 흔들었고, 특히 자동차 및 소비재 관련 종목들이 큰 영향을 받았다. 제너럴 모터스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>)와 포드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)는 <a href="https://www.benzinga.com/25/03/44520779/stocks-slip-gold-rallies-auto-tariffs-benefit-tesla-rivian-punish-gm-ford-whats-driving-markets-thursday">투자자들이 높은 비용과 낮은 수요를 우려하면서 급락</a>했다. 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)와 리비안(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>)처럼 국내에서 제조하는 회사들은 안전하게 있었다.
전반적인 시장도 <a href="https://www.benzinga.com/news/25/03/44546899/trumps-25-auto-tariffs-rattle-wall-street-feds-favorite-inflation-gauge-surges-consumer-price-worries-rocket-this-week-in-markets">무역 긴장과 예상보다 높은 인플레이션 수치</a>로 인해 투자자들이 조심스러워 하면서 활력이 낮았다. 2월의 핵심 개인소비지출(PCE) 물가 지수는 전년 대비 2.8% 상승했으며, 예상치인 2.7%를 초과했다. 이는 연방준비제도(연준)의 금리 인하 경로에 대한 재고를 초래하며, 조기 통화 완화에 대한 기대를 약화시켰다.
금요일에 미시간 대학교 소비자 신뢰 조사에서는 미국인들이 향후 5년 동안 평균 4.1%의 인플레이션을 예상한다고 밝혀 더욱 우울한 그림을 그렸다. 이는 1993년 2월 이후 가장 높은 수치이다. 이러한 수치 속에서 소비자 신뢰는 2022년 11월 이후 최저 수준으로 떨어졌다.
<div class="ticker-wrapper">
<div class="sc-dkXDdO xikqE ticker-box-wrapper">
<div class="sc-hZlppA ddOBfh get-report-button flex">
<div></div>
</div>
</div>
</div>
말할 필요도 없이, 안전 자산이 선호되었다. 금 가격은 시장 변동성으로부터 안전을 찾는 투자자들로 인해 사상 최고치로 상승했고, 국채 수익률은 연준의 정책 기대치가 재조정되면서 급등했다.
한편, 미국의 부채 대비 GDP 비율은 2029년까지 제2차 세계대전 최고치를 초과하고, 2055년까지는 156%에 이를 것으로 예상되며, 이는 장기적인 경제 불확실성을 더하는 요소가 된다.
다음 읽기: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44545009/big-moves-at-intelthese-3-etfs-stand-to-benefit">인텔의 큰 변화: 이 3개의 ETF가 혜택을 볼 것이다</a></li>
</ul>
사진: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Direxion Shares ETF Trust Direxion Daily AI and Big Data Bear 2X Shares

뉴스

에 대한 최신 뉴스 Direxion Shares ETF Trust Direxion Daily AI and Big Data Bear 2X Shares (ARCA:AIBD)

월요일, 3월 31, 2025

뉴스

파트너 / 기고자

벤징가 글로벌